HOPE Center News

Researchers at the UA and Banner Health will create alerts to identify patients at risk for developing heart rhythm disorders and sudden cardiac death.

Findings were published in JAMA Network Open.

The research team conducted a meta-analysis to evaluate the safety and efficacy of direct oral anticoagulants (DOACs) in patients with cancer.

Congrats to Dr. Bhattacharjee!

HOPE Center investigators Daniel Malone, RPH, PhD, FAMCP, and Amy Grizzle, PharmD, recently published a new study assessing methods used to find evidence about potential drug-drug interactions (PDDIs).

HOPE Center doctoral students and faculty collaborate in this new cost-effectiveness study.

Insight from Dr. Khalid Eljaaly, a post-doctoral fellow alumni.

Health and Pharmaceutical Outcomes graduate student, Srujitha Marupuru, PharmD presented her research at the 2018 ACCP Global Conference.

Though there are currently only 12 biosimilars approved by the Food and Drug Administration (FDA), there are many more in the pipeline, and the oncology world is bracing itself for their impact. How will they be incorporated into practice? What will it mean for the health care ecosystem?

UA students were introduced to the principles and applications of health outcomes research, and discussed related career tracks in the pharmaceutical industry, academia, and managed care.

Dr. Hurwitz led the group through developing and analyzing a decision model.

Honorary research fellows for the HOPE Center received high-profile recognition for recent work.

The algorithms will be incorporated into electronic health record systems to alert providers about relevant, patient-specific, potential drug interactions.